REPROCELL EUROPE LIMITED

Company description

REPROCELL provides a range of products and services to support life sciences research. Specialist areas include stem cells, tissue engineering and human tissues. REPROCELL's services are offered on a contract research basis, spanning preclinical and clinical research. The contract testing services include: - custom manufacturing of pluripotent stem cells, including gene edited cells - the assessment of drug safety and efficacy by the use of human fresh tissues and engineered tissues - molecular biology services including RNA and DNA extraction. Key products include: - RNA technologies to create induced pluripotent stem cells and support their differentiation to mature cells, including RNA reprogramming, small molecules, growth factors, antibodies and cell culture media - Laboratory instrumentation to support stem cell culture - A range of stem cells including induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs) - Tissue engineering products including scaffolds for 3D cell culture - A biorepository to support medical research

Expertise

Industry

Biotechnology and pharmaceuticals, Life sciences

REPROCELL EUROPE LIMITED case studies

Helping new medicines gain regulatory approval

Reprocell offers contract testing services to demonstrate the safety and effectiveness of potential medicines, before clinical trials, including this example in lung disease.

Case study